Acclinate
Diversity in Clinical Trials

Acclinate, HCN Global Partner to Expand Hispanic & Latino Clinical Research Access

May 28, 2026

Acclinate

Acclinate and HCN Global today unveiled a strategic, research-ready partnership bridging two of industry's most trusted multicultural health engagement networks. The collaboration combines Acclinate's NOWINCLUDED platform of 220K+ members and HCN Global's La Red Hispana, LatinEQUIS, and Melanin Thriving platforms of 290K+ individuals to enable measurable, predictive end-to-end clinical trial health engagement across historically underrepresented communities for pharmaceutical and public health partners.

Built on a foundation of shared values and strategic planning, the partnership is operational. HCN Global is now a licensed user of Acclinate's e-DICT™ platform, with API integrations in place across HCN Global's owned channels. The integration enables life sciences and pharmaceutical sponsors and public health agencies to track engagement, measure trust-building activity, and leverage Acclinate's patented Participation Probability Index (PPI) to predict clinical trial readiness across Acclinate and HCN Global's combined networks.

Together, Acclinate and HCN Global will deploy trusted digital and grassroots activations across Black/African American and Hispanic and Latino communities to improve education around health conditions that disproportionately impact these communities, build trust, and sustain long-term engagement to ultimately increase clinical trial awareness and participation willingness.

"True representation in clinical research demands more than good intentions — it requires authentic community trust. By partnering with HCN Global, we aren't just reaching Hispanic and Latino populations; we're measuring who's engaging, predicting who's ready to participate, and identifying exactly where the path to participation breaks down. That's how industry moves from performative engagements to sustained and culturally relevant actions."Del Smith, CEO of Acclinate.

"For years, HCN Global has been building relationships with Hispanic and Latino communities around health, not as a campaign, but as a commitment,"said Alison Rodden, CEO of HCN Global."Partnering with Acclinate gives us the technology to show sponsors and partners exactly what community trust looks like as data: who we're reaching, how they're engaging, and what it takes to convert that into clinical trial participation. This is the relationships-based infrastructure the industry has been missing."

As part of the long-term roadmap, Acclinate will build a dedicated HCN Global-branded community space within NOWINCLUDED, creating a culturally tailored digital hub for Spanish-language health education, community programming, and trial participation readiness, extending the reach of HCN Global's existing platforms into a persistent, measurable engagement environment.

The partnership supports clinical trial sponsors with accessing, engaging, and mobilizing Black and Hispanic communities across 35+ therapeutic areas.

Acclinate is a digital health equity company that turns community trust into clinical trial diversity. Its patented e-DICT™ platform and NOWINCLUDED community bring together predictive engagement technology and culturally grounded outreach to help sponsors recruit and retain participants who reflect the real world.

HCN Global is an award-winning, culture-driven, data-informed multicultural health communications agency serving government, nonprofit, philanthropic, and life sciences partners. Its La Red Hispana, LatinEQUIS, and Melanin Thriving multimedia networks and community partnerships reach millions of people weekly across Hispanic/Latino, Black/African American, AAPI, American Indian/Alaska Native Tribal, and rural communities. This reach is strengthened by 450 affiliated media outlets, 1,000+ community and health workers, and 100+ national and local partners working at scale with one mission: to improve quality of life.

Acclinate Contact:
Lauren Clements
Head of Marketing
lauren.clements@acclinate.com

HCN Global Contact:
LeShaundra Cordier
Vice President of Growth and Impact
leshaundra.cordier@hcnglobal.com

Media Contact:
Lauren Clements
lauren.clements@acclinate.com
LeShaundra Cordier
leshaundra.cordier@hcnglobal.com

March 16, 2026

Inc. Names Acclinate Co-Founder Tiffany Whitlow to Its 2026 Female Founders 500 List

December 12, 2025

Acclinate Named Bronze Winner for Digital Health Innovation at the 5th Annual Anthem Awards

December 2, 2025

Acclinate Recognized as a Vet100 Fastest-Growing Veteran-Owned Business

January 28, 2026

Acclinate Releases 2025 Annual Impact Report Highlighting Community-Led Progress in Health Equity

May 20, 2026

International Clinical Trials Day Renews Focus on Representation in Medical Research

February 2, 2026

Acclinate Scales National Reach for Hispanic and Indigenous Communities; Announces New 30-Day Mobilization Commitment

May 28, 2026

Acclinate, HCN Global Partner to Expand Hispanic & Latino Clinical Research Access

February 23, 2024

First-Ever Black Maternal Health Expo Coming to Birmingham

February 23, 2024

Minority-owned biotech startup expanding, adding employees

April 10, 2024

10 Best Tech Startups in Alabama

February 26, 2024

Alabama Regional Medical Services, Acclinate Create New Partnership

February 23, 2024

2023 Best Tech Startups in Alabama

April 11, 2024

Acclinate Co-Founder Tiffany Whitlow Named a Top 250 Female Founder by Inc.

February 26, 2024

Acclinate: Helping People of Color Take Control of Their Health

February 26, 2024

Meet the Birmingham Pastor Igniting Health Equity for the Local Community

May 7, 2024

Acclinate Raises $7M in Series A Funding to Accelerate Health Equity Revolution

February 26, 2024

Adding Color to Clinical Studies

February 26, 2024

Solving The Lack of Diversity In Clinical Trials With Acclinate’s Del Smith

October 28, 2024

Acclinate Announces New Undergraduate & Graduate Academic Scholarships

August 5, 2024

Acclinate and Housing Authority of the Birmingham District Partner to Improve Health Equity

February 26, 2024

Trialbee Inks Deal with Acclinate in Push for Trial Diversity

October 28, 2024

Acclinate Appoints Dr. Ivor Braden Horn to Board of Directors to Advance Health Equity Mission

February 23, 2024

Walladean Streeter, hero of Bush Hills, on why you need to get involved

February 19, 2024

This Local Survivor of Long COVID—Why His Story Is Important

April 24, 2024

Acclinate Empowers Black Maternal Health with AI-Powered Cultural Understanding

February 26, 2024

Acclinate and Prosper Partner on New Platform Aimed at Reducing Health Disparities

April 10, 2024

Acclinate and Egality Sciences Unite for Health Equity in Hispanic and African American Communities

February 26, 2024

Acclinate Races Against The Clock To Increase Diversity In Clinical Drug Trials

February 26, 2024

J&J’s incubator makes health equity high priority for selecting new partners

November 25, 2025

NOWINCLUDED Expands Its Mission with Launch of Unfiltered Podcast

September 18, 2024

Acclinate Recognized Among Best Workplaces for Innovators: Healthcare at Fast Company Innovation Festival

April 8, 2024

Merck turns to Acclinate to increase African American participation in cancer trials

October 20, 2025

Acclinate Named to Inc. 5000 List of America’s Fastest-Growing Private Companies

February 26, 2024

Acclinate Creates New Webpage to Inform More Minorities About COVID-19 Vaccine

August 13, 2024

Acclinate Ranks No. 539 on the 2024 Inc. 5000 List

April 10, 2024

Bridging the Gap: Startups Exploring Diversity in Genetics and Biotechnology Research

December 5, 2025

Acclinate Recognized as a Vet100 Fastest-Growing Veteran-Owned Business

January 9, 2026

Acclinate Named Bronze Winner for Digital Health Innovation at the 5th Annual Anthem Awards

February 23, 2024

Birmingham’s Walladeen Streeter, Health Care Champion for a Better Bush Hills Community

April 11, 2024

The Pharmaverse Podcast: Health Equity & Diversity in Clinical Trials with Camille Pope

February 26, 2024

Why Amazon, Google, and Other Big Businesses Have Launched Accelerators to Help Minority-Owned Startups

February 26, 2024

Acclinate Named Fast Company’s ‘World Changing Ideas: Health’ Awards Finalist with Honorable Mentions

February 2, 2026

Acclinate Scales National Reach for Hispanic and Indigenous Communities; Announces New 30-Day Mobilization Commitment

December 17, 2025

NOWINCLUDED Expands Its Mission with Launch of Unfiltered Podcast

August 19, 2025

Mommy Listening Tour at Babypalooza

Ready to Reduce Risk and Accelerate Your Pipeline?

Your next breakthrough needs real people, real trust, and real data. Acclinate delivers all three— end to end.